- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Omkar Pharmachem Limited has announced its Annual Secretarial Compliance Report for the financial year 2024-25, issued by Maulik Bhavsar & Associates. The report confirms full compliance with applicable SEBI regulations and listing obligations during the year, with no deviations or non-compliances observed. All required policies have been adopted and updated timely, disclosures were made within prescribed limits, and there were no director disqualifications or auditor resignations. The company maintains proper records, conducts board and committee evaluations, and complies with insider trading norms, ensuring robust corporate governance and regulatory adherence.